269 related articles for article (PubMed ID: 30121369)
21. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
22. Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.
Yasir S; Chen ZE; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson MS
Am J Surg Pathol; 2022 Jun; 46(6):786-792. PubMed ID: 35383587
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Adenomas: Classification, Controversies, and Consensus.
Torbenson M
Surg Pathol Clin; 2018 Jun; 11(2):351-366. PubMed ID: 29751879
[TBL] [Abstract][Full Text] [Related]
24. [Malignant transformation of multiple isolated hepatocellular adenomas. Therapeutic implications of immunohistochemical and radiological findings].
Baulieux J; Manichon AF; Bancel B; D'Errico E; Raspado O; Ducerf C; Mabrut JY; Rode A
Bull Acad Natl Med; 2012 Feb; 196(2):459-81; discussion 482-3. PubMed ID: 23420963
[TBL] [Abstract][Full Text] [Related]
25. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
26. Maturity-onset diabetes of the young and hepatic adenomatosis - characterisation of a new mutation.
Iwen KA; Klein J; Hubold C; Lehnert H; Weitzel JM
Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):368-71. PubMed ID: 23616187
[TBL] [Abstract][Full Text] [Related]
27. Unexpected discovery of 2 cases of hepatocyte nuclear factor 1alpha-mutated infracentimetic adenomatosis.
Laumonier H; Rullier A; Saric J; Balabaud C; Bioulac-Sage P
World J Gastroenterol; 2008 Aug; 14(30):4830-3. PubMed ID: 18720549
[TBL] [Abstract][Full Text] [Related]
28. New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma.
Sakellariou S; Morgan Y; Heaton N; Portmann B; Quaglia A; Tobal K
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):623-7. PubMed ID: 21566527
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
Hahn E; Putra J
World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
[TBL] [Abstract][Full Text] [Related]
30. Hepatic adenomas caused by somatic HNF1A mutations in children with biallelic mismatch repair gene mutations.
Holter S; Pollett A; Zogopoulos G; Kim H; Schwenter F; Asai K; Gallinger S; Clendenning M; Steinbach G; Jacobson A; Boycott KM
Gastroenterology; 2011 Feb; 140(2):735-6. PubMed ID: 21182953
[No Abstract] [Full Text] [Related]
31. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.
Stueck AE; Qu Z; Huang MA; Campreciós G; Ferrell LD; Thung SN
Semin Liver Dis; 2015 Nov; 35(4):444-9. PubMed ID: 26676820
[TBL] [Abstract][Full Text] [Related]
35. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Nault JC; Mallet M; Pilati C; Calderaro J; Bioulac-Sage P; Laurent C; Laurent A; Cherqui D; Balabaud C; Zucman-Rossi J
Nat Commun; 2013; 4():2218. PubMed ID: 23887712
[TBL] [Abstract][Full Text] [Related]
36. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
37.
Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular adenoma with a double mutation HNF1A and IDH1 in a patient with Ollier disease.
Cappellen D; Catry-Thomas I; Castain C; Bioulac-Sage P
Liver Int; 2021 Dec; 41(12):3009-3010. PubMed ID: 34582629
[No Abstract] [Full Text] [Related]
39. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
40. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.
Mounajjed T; Yasir S; Aleff PA; Torbenson MS
Mod Pathol; 2015 Sep; 28(9):1265-74. PubMed ID: 26205181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]